Study Stopped
No time to pursue this research.
Multiparameter Optimized tES for Memory in Aging
Concurrent Multiparameter Optimized Noninvasive Brain Stimulation for Working Memory in Aging
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
With an aging population worldwide, it is critical to develop effective interventions promoting healthy cognitive aging. Transcranial electrical stimulation (tES) is a promising but not fully realized noninvasive brain stimulation approach that could improve memory. This study investigates the behavioral and electrocortical effects of personalized tES in aging to determine whether whether optimal dosing, electrode placements, and waveforms elicit stronger responses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Dec 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 17, 2024
CompletedFirst Posted
Study publicly available on registry
July 9, 2024
CompletedStudy Start
First participant enrolled
December 31, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
Study Completion
Last participant's last visit for all outcomes
December 31, 2027
February 25, 2026
February 1, 2026
Same day
April 17, 2024
February 23, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Electrocortical EEG changes pre- to post-tES
Observe effects of each tES condition within each of the 5 sessions, as measured by TMS-EEG
1 year
N-back working memory changes pre- to post-tES
Observe effects of each tES condition within each of the 5 sessions on the N-back memory task
1 year
Secondary Outcomes (1)
Rate of side effects from tES
1 year
Study Arms (5)
Personalized tES stimulation #1
EXPERIMENTALtES will be applied with personalized parameters in condition #1 for approximately 20 minutes.
Personalized tES stimulation #2
EXPERIMENTALtES will be applied with personalized parameters in condition #2 for approximately 20 minutes.
Personalized tES stimulation #3
EXPERIMENTALtES will be applied with personalized parameters in condition #3 for approximately 20 minutes.
Standard tES
EXPERIMENTALStandard tES will be applied in condition #4 for approximately 20 minutes.
Sham tES stimulation
SHAM COMPARATORA sham (placebo) comparison condition will be applied in condition #5 for approximately 20 minutes.
Interventions
We will administer active transcranial electrical stimulation in one of the 4 active stimulation conditions and 1 sham stimulation condition.
Eligibility Criteria
You may qualify if:
- y.o.
- Endorse good health with no history of mental or physical illness
- Willingness to adhere to the study schedule and assessments
- Able to read consent document and provide informed consent.
- English is a first or primary fluent language.
You may not qualify if:
- Any current psychiatric diagnosis or current Clinical Global Impression ratings of psychiatric illness \> 1
- Neurodevelopmental disorders, history of Central Nervous System (CNS) disease, concussion, overnight hospitalization, or other neurologic sequela, tumors, seizures, meningitis, encephalitis, or abnormal CT or MRI of the brain
- Any psychotropic medication is taken within 5 half-lives of procedure time
- Any head trauma resulting in loss of consciousness
- Visual impairment (except the use of glasses)
- Inability to complete cognitive testing
- Active participation or plan for enrollment in another evidence-based clinical trial affecting the psychosocial function
- Repeated abuse or dependence upon drugs (excluding nicotine and caffeine) or taking medications including stimulants, modafinil, thyroid medication, or steroids
- Implanted devices/ferrous metal of any kind
- History of seizure or epilepsy, currently taking medications that lower seizure thresholds
- Claustrophobia or other conditions that would prevent the MRI assessment.
- Pregnancy (or suspected/possible pregnancy or plan to become pregnant in the short term).
- Urine Pregnancy Test: If the subject is a woman of childbearing potential and /or a man capable of fathering a child before, during, and/or after participation precautions should be taken. Examples of acceptable methods of birth control for participants involved in the study include birth control pills, patches, Intrauterine Devices (IUD), condoms, sponges, diaphragm with spermicide, or avoiding sexual activity that could cause the subject to become pregnant.
- Inability to adhere to the treatment schedule.
- Inability to fit the wearable device to the user's head.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kevin Caulfield, PhD
Medical University of South Carolina
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- Double-blind, sham-controlled
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
April 17, 2024
First Posted
July 9, 2024
Study Start (Estimated)
December 31, 2026
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2027
Last Updated
February 25, 2026
Record last verified: 2026-02